Depositphotos 60816667 l


A STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF FINERENONE VERSUS PLACEBOIN PARTICIPANTS WITH CHRONIC KIDNEY DISEASE AND TYPE 1 DIABETESAND IN DELAYING THE PROGRESSION OF CHRONIC KIDNEY DISEASE.

To be included in the study:
Participant must be ≥18 years of age and have Type 1 Diabetes
Diabetes continuously treated with insulin, started within one year from diagnosis.
HbA1c at Screening <10%
eGFR ≥25 and <90 mL/min/1.73 m2
UACR ≥200 mg/g (22.6 mg/mmol) to <5000 mg/g (565 mg/mmol)
 
Back to ongoing clinical Trials